IN THE SPOTLIGHT

With tislelizumab, BeiGene brings immunotherapy to more patients in Europe

With tislelizumab, BeiGene brings immunotherapy to more patients in Europe

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment

Sylvester Study Highlights Global Trends in Lung Cancer Risk Factors: Tobacco, Pollution, and Asbestos

Sylvester Study Highlights Global Trends in Lung Cancer Risk Factors: Tobacco, Pollution, and Asbestos

Yvonne Diaz on the hopes and concerns of cancer patients regarding the use of AI wearables – Lung Cancer Europe

Yvonne Diaz on the hopes and concerns of cancer patients regarding the use of AI wearables – Lung Cancer Europe

Ponsegromab Reduces Symptoms Linked to Cancer Cachexia, Elevated GDF-15

Ponsegromab Reduces Symptoms Linked to Cancer Cachexia, Elevated GDF-15

Low ctDNA Levels are Prognostic of Outcomes in Early-Stage Lung Adenocarcinoma

Low ctDNA Levels are Prognostic of Outcomes in Early-Stage Lung Adenocarcinoma

Charles Swanton: Ultrasensitive ctDNA detection for early-stage NSCLC stratification

Charles Swanton: Ultrasensitive ctDNA detection for early-stage NSCLC stratification

Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight

Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight

Dr Riess on the Investigation of Ivonescimab in Advanced NSCLC

Dr Riess on the Investigation of Ivonescimab in Advanced NSCLC